New Report Connects Healthy Ageing to Economic Growth, Calling on G20 Leaders to Look to Vaccine Policy as a Critical Lever

Expert organizations point to adult immunization as a means to advance better health for citizens, fiscal sustainability, and economic growth across the rapidly ageing G20

New York, NEW YORK & Tokyo, JAPAN (August 5, 2019) – Today, the Global Coalition on Aging (GCOA) and the Health and Global Policy Institute (HGPI) published a new report, Measures to Ensure Healthy Ageing. The report connects economic growth and fiscal sustainability to healthy ageing and preventive healthcare measures, and points, in particular, to vaccines for adults as a key strategy. The report summarizes recommendations based on a policy roundtable convened by GCOA and HGPI, on June 5, alongside the G20 Finance Ministers Meeting.

“Japan’s focus on ageing as a major theme of our G20 leadership and status as the world’s oldest nation gives us a platform to highlight the connections between healthy ageing and a healthy economy,” said Ryoji Noritake, CEO of HGPI. “Sending a clear message about the value and importance of vaccines at all ages, and particularly for adults, is an opportunity for Japan to demonstrate our leadership, not just in business and innovation, but also on healthy ageing. Our ability to ensure lasting health for our ageing population will increasingly define our future success as a society and as an advanced economy.”

The June roundtable, which took place at the Nikkei Head Office in Tokyo, brought together global and Japanese leaders from government, the private sector, academia, and global institutions to recommend policy directions for G20 Leaders attending the Finance Meeting, as well as those who will be attending the Health Ministers Meeting in October.

HGPI and GCOA jointly developed the following policy recommendations coming out of discussion at the roundtable:

  • Policy dialogue conversations on fiscal sustainability must consider how economic growth can be integrated with ageing, where vaccines for all ages can play a central role;
  • Governments and national leaders must strengthen preventative healthcare measures, which are crucial to economic growth and healthy ageing;
  • Government must bolster efforts to communicate the safety, efficacy, value, and further innovation of vaccines, which are vital to preventative healthcare measures; and
  • Multi-sector collaboration is essential to the promotion of healthy ageing, preventative healthcare measures, and vaccine uptake.

“With 100 year lives rapidly becoming the norm in G20 countries, and older adults the fastest growing age group, the future sustainability of our public health systems and continued economic growth increasingly rest on our ability to extend the health, wellbeing, and productivity of older adults,” said Global Coalition on Aging CEO, Michael Hodin. “Vaccines, long a public health best practice for children, must now become a central feature of countries’ healthy ageing and health prevention strategies for our 21st century, where there are more old than young. Policies to advance vaccines for adults are among the most cost-efficient and health-effective strategies we have at hand.”

About the Health and Global Policy Institute
The Health and Global Policy Institute (HGPI) is a Tokyo-based independent and non-profit health policy think tank, established in 2004. Since its establishment, HGPI has been working to help citizens shape health policies by generating policy options, and to bring stakeholders together as a non-partisan think-tank. HGPI’s mission is to improve the civic mind and the well-being of individuals, and to foster sustainable, healthy communities by shaping ideas and values, reaching out on global needs, and influencing society. HGPI is committed to activities that bring together relevant players in different fields, in order to provide innovative and practical solutions, and to help interested citizens understand policy options from a global, broad, and long-term perspective. For more information, visit https://hgpi.org/en/.

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

GCOA Sign-on Letter to Governor Spanberger: Consequences of Importing Federal Price Caps on Virginians’ Access to Medicine & Healthy Aging Opportunities

Dear Governor Spanberger: We, the undersigned organizations, bring deep, on‑the‑ground experience serving older Americans, patients managing complex and chronic conditions, and their caregivers across Virginia and nationwide. We also have a clear understanding of which policies and programs are effective and where they fall short.

New Report Summarizes State of Expert Opinions on Japan’s Adult Vaccine Policy as Population Shifts Older

The Global Coalition on Aging (GCOA), Health and Global Policy Institute (HGPI), and the Asia-Pacific Consortium for Healthy Aging and Adult Immunization (AP-CHAAI) today announced the launch of Strengthening Vaccine Policy for Healthy Aging and Economic Growth in Japan, a landscape analysis examining the state of vaccine policy in super-aging Japan. Based on a comprehensive review of over 100 policy documents, recommendations, reports, academic papers, and gray literature articles, the report, which was funded by GSK, summarizes the latest academic research and policy discourse around adult vaccines.

WSJ Letter to the Editor: How Flu Vaccine Policies Affect the Economy

Your editorial “Vinay Prasad’s Vaccine Kill Shot” (Review & Outlook, Feb. 12) points out that a recent decision by Mr. Prasad, the leader of the Food and Drug Administration’s vaccine division, will have negative consequences. Mr. Prasad’s decision to reject Moderna’s flu vaccine without even reviewing it is even worse than you describe. Denying us a new, innovative flu vaccine is horrible health policy. Innovation is at risk because, as Moderna’s CEO has said, if the largest market is off limits, investments won’t be made. But the decision will also have economic consequences. Investment in preventive health is critical as our population ages. In its April 2025 World Economic Outlook report, the International Monetary Fund dedicated an entire chapter to the need for healthier longevity as the global population ages.

Joe Biden’s ‘Cancer Moonshot’ May be Derailed by New Policies, Including His Own

For almost a decade, President Biden has championed a bold “cancer moonshot” — an initiative he first launched in 2016, revived early in his administration, and reiterated during this year’s State of the Union. It is a laudable goal, especially for an aging nation where cancer and chronic disease are on the rise. There’s just one problem: Recent federal and state policies are poised to derail the incredible progress made in oncology since 2016. A rash of policies now threatens to limit access and slow progress towards new breakthroughs.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

Kishida and Biden Face a Similar Demographic Crisis

Your front page story “Japan wrestles with age-old problem as population declines at record rate” (Report, April 13) and the letter in the same edition from Tim Hill, “A gently declining population is no reason to panic”, both describe what all societies face as they modernise in the 21st century.

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.